NON-EXCLUSIVE DISTRIBUTION AGREEMENT between DEXCOM, INC. and RGH Enterprises, Inc. Dated April 30, 2008Non-Exclusive Distribution Agreement • August 3rd, 2009 • Dexcom Inc • Surgical & medical instruments & apparatus • California
THIS NON-EXCLUSIVE DISTRIBUTION AGREEMENT (the “Agreement”) is made April 30, 2008 by and between DexCom, Inc., a Delaware corporation, with a principle place of business at 6340 Sequence Drive, San Diego, California 92121 (the “Company”) and RGH Enterprises, Inc., an Ohio corporation with a principle office at 1810 Summit Commerce Park, Twinsburg, Ohio 44087 (the “Distributor”). The Company and the Distributor are referred to individually as a “Party” and collectively as the “Parties”.
DexCom, Inc. 6340 Sequence Drive San Diego, CA 92121 Edwards Lifesciences, LLC One Edwards Way Irvine, CA 92614Dexcom Inc • August 3rd, 2009 • Surgical & medical instruments & apparatus
On November 10, 2008, Edwards Lifesciences LLC (“Edwards”) and DexCom, Inc. (“DexCom”) entered into a Collaboration Agreement (the “Agreement”), pursuant to which DexCom, in part, agreed to undertake certain development obligations, and Edwards agreed to fund DexCom’s development obligations related to an in-hospital blood glucose monitoring system. Under the Agreement, DexCom’s development obligations include, among other things, completion of clinical trials for the first generation product under development to support an application for regulatory approval (the “Clinical Trials”).
